Whole cell lysate (WCL) for BJAB ERAAP-dsRed clones B2 and D4 was made using RIPA lysis buffer (150 mM NaCl, 1% Triton X-100, 5% Na Deoxycholate, 1% SDS, 50 mM Tris pH 8 in water) with Protease inhibitors (Roche, 11836170001). WCL lysate was incubated on ice for 30 min and centrifuged at max speed for 10 min to remove debris. Cleared lysate was transferred to a new tube and anti-ERAAP L1 antibody (1:200 dilution) was added. Samples were incubated rotating overnight at 4 °C. The next day, ERAAP was immunoprecipitated by adding 40 ul of Protein A Dynabeads (Invitrogen, 10001D) to each sample and incubating an additional 2 hr. Using a magnet, beads containing ERAPP were captured. Beads were washed four times with 50 mM Tris, 150 mM NaCl in water. Endo H assay was performed following manufacturer’s instructions (New England Biolabs, P0702S). Following addition of Glycoprotein Denaturing Buffer, each sample was aliquoted into two tubes. 1 ul of EndoH (Endo H +) or 1 ul of water (Endo H -) was then added to each tube. Samples were incubated for 1 h at 37 °C. ERAAP’s glycosylation state was assessed by western blot. Membrane was probed using anti-ERAAP L1 antibody (1:000 dilution). Anti-ERAAP L1 was produced in the Shastri lab.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.